JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266598

Human PARP1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

PARP1 KO cell line available to order. KO validated by Flow Cytometry, Immunocytochemistry, Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

Poly [ADP-ribose] polymerase 1, PPOL, Poly[ADP-ribose] synthase 1, PARP1, Protein poly-ADP-ribosyltransferase PARP1, PARP-1, NAD(+) ADP-ribosyltransferase 1, ADPRT 1, ADP-ribosyltransferase diphtheria toxin-like 1, ADPRT, ARTD1, DNA ADP-ribosyltransferase PARP1

13 Images
Flow Cytometry (Intracellular) - Human PARP1 knockout HEK-293T cell line (AB266598)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Human PARP1 knockout HEK-293T cell line (AB266598)

HEK293T wild-type and PARP1 knockout cells (ab266598) were labelled with a green or violet, fluorescent dye, respectively. Wild-type and knockout cells were mixed in a 1 : 1 ratio, fixed in 4% PFA and permeabilized in 0.1% Triton X-100.

Antibody staining was quantified using the Attune NxT Flow Cytometer with representative images showing the staining intensity in the knockout population (pink histogram, dashed line) compared to the wild-type cells (green histogram, solid line). Histograms with dotted lines represent secondary antibody-only controls in both wild-type and knockout cells.

Antibody dilution : 0.5 μg/μL.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Flow Cytometry (Intracellular) - Human PARP1 knockout HEK-293T cell line (AB266598)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Human PARP1 knockout HEK-293T cell line (AB266598)

HEK293T wild-type and PARP1 knockout cells (ab266598) were labelled with a green or violet, fluorescent dye, respectively. Wild-type and knockout cells were mixed in a 1 : 1 ratio, fixed in 4% PFA and permeabilized in 0.1% Triton X-100.

Antibody staining was quantified using the Attune NxT Flow Cytometer with representative images showing the staining intensity in the knockout population (pink histogram, dashed line) compared to the wild-type cells (green histogram, solid line). Histograms with dotted lines represent secondary antibody-only controls in both wild-type and knockout cells.

Antibody dilution : 0.1 μg/μL.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Immunocytochemistry/ Immunofluorescence - Human PARP1 knockout HEK-293T cell line (AB266598)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Human PARP1 knockout HEK-293T cell line (AB266598)

ab32071 was shown to react with PARP1 in wild-type HEK293T cells in immunocytochemistry with loss of signal observed in PARP1 knockout cell line ab266598. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab32071 at 1/50 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 μg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss (LSM-880).

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Immunocytochemistry/ Immunofluorescence - Human PARP1 knockout HEK-293T cell line (AB266598)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Human PARP1 knockout HEK-293T cell line (AB266598)

ab32378 was shown to react with PARP1 in wild-type HEK293T cells in immunocytochemistry with loss of signal observed in PARP1 knockout cell line ab266598. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab32378 at 1/500 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 μg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss (LSM-880).

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Immunocytochemistry/ Immunofluorescence - Human PARP1 knockout HEK-293T cell line (AB266598)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Human PARP1 knockout HEK-293T cell line (AB266598)

ab32138 was shown to react with PARP1 in wild-type HEK293T cells in immunocytochemistry with loss of signal observed in PARP1 knockout cell line ab266598. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab32138 at 1/50 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 μg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss (LSM-880).

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Flow Cytometry (Intracellular) - Human PARP1 knockout HEK-293T cell line (AB266598)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Human PARP1 knockout HEK-293T cell line (AB266598)

HEK293T wild-type and PARP1 knockout cells (ab266598) were labelled with a green or violet, fluorescent dye, respectively. Wild-type and knockout cells were mixed in a 1 : 1 ratio, fixed in 4% PFA and permeabilized in 0.1% Triton X-100.

Antibody staining was quantified using the Attune NxT Flow Cytometer with representative images showing the staining intensity in the knockout population (pink histogram, dashed line) compared to the wild-type cells (green histogram, solid line). Histograms with dotted lines represent secondary antibody-only controls in both wild-type and knockout cells.

Antibody dilution : 0.1 μg/μL.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)
  • WB

Lab

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)

Lanes 1- 2 : Merged signal (red and green). Green - ab32138 observed at 113 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab32138 was shown to react with PARP1 in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266598 (knockout cell lysate ab257017) was used. Wild-type HEK-293T and PARP1 knockout HEK-293T cell lysates were subjected to SDS-PAGE. ab32138 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4° at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PARP1 antibody [E102] (<a href='/en-us/products/primary-antibodies/parp1-antibody-e102-ab32138'>ab32138</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

PARP1 knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human PARP1 knockout HEK-293T cell line (ab266598)

Predicted band size: 113 kDa

Observed band size: 113 kDa

false

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)
  • WB

Supplier Data

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)

ab32378 was shown to react with PARP1 in wild-type HEK293T cells in Western blot with loss of signal observed in PARP1 knockout cell line ab266598. Wild-type HEK293T and PARP1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab32378 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-PARP1 antibody [Y17] (<a href='/en-us/products/primary-antibodies/parp1-antibody-y17-ab32378'>ab32378</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK293T lysate at 30 µg

Lane 2:

PARP1 knock-out HEK293T lysate at 30 µg

Lane 2:

Western blot - Human PARP1 knockout HEK-293T cell line (ab266598)

Predicted band size: 113 kDa

false

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)
  • WB

Supplier Data

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)

ab32071 was shown to react with PARP1 in wild-type HEK293T cells in Western blot with loss of signal observed in PARP1 knockout cell line ab266598. Wild-type HEK293T and PARP1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab32071 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-PARP1 antibody [E78] (<a href='/en-us/products/primary-antibodies/parp1-antibody-e78-ab32071'>ab32071</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK293T lysate at 30 µg

Lane 2:

PARP1 knock-out HEK293T lysate at 30 µg

Lane 2:

Western blot - Human PARP1 knockout HEK-293T cell line (ab266598)

Predicted band size: 113 kDa

false

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)
  • WB

Supplier Data

Western blot - Human PARP1 knockout HEK-293T cell line (AB266598)

ab32138 was shown to react with PARP1 in wild-type HEK293T cells in Western blot with loss of signal observed in PARP1 knockout cell line ab266598. Wild-type HEK293T and PARP1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab32138 overnight at 4 °C at a 1/5000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-PARP1 antibody [E102] (<a href='/en-us/products/primary-antibodies/parp1-antibody-e102-ab32138'>ab32138</a>) at 1/5000 dilution

Lane 1:

Wild-type HEK293T lysate at 30 µg

Lane 2:

PARP1 knock-out HEK293T lysate at 30 µg

Lane 2:

Western blot - Human PARP1 knockout HEK-293T cell line (ab266598)

Predicted band size: 113 kDa

false

Sanger Sequencing - Human PARP1 knockout HEK-293T cell line (AB266598)
  • Sanger seq

Lab

Sanger Sequencing - Human PARP1 knockout HEK-293T cell line (AB266598)

Sequencing chromatogram displaying sequence edit in exon 2

Sanger Sequencing - Human PARP1 knockout HEK-293T cell line (AB266598)
  • Sanger seq

Unknown

Sanger Sequencing - Human PARP1 knockout HEK-293T cell line (AB266598)

Homozygous : 1 bp insertion in exon 2

Cell Culture - Human PARP1 knockout HEK-293T cell line (AB266598)
  • Cell Culture

Unknown

Cell Culture - Human PARP1 knockout HEK-293T cell line (AB266598)

Representative images of PARP1 knockout HEK293T cells, low and high confluency examples (top left and right respectively) and wild-type HEK293T cells, low and high confluency (bottom left and right respectively) showing typical adherent, epithelial-like morphology. Images were captured at 10X magnification using an EVOS M5000 microscope.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Flow Cytometry,Immunocytochemistry,Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266598-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266598-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266598 Human PARP1 knockout HEK-293T cell line", "number":"AB266598-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266598-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266598-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266598 Human PARP1 knockout HEK-293T cell line", "number":"AB266598-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266598-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266598 Human PARP1 knockout HEK-293T cell line", "number":"AB266598-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266598-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266598 Human PARP1 knockout HEK-293T cell line", "number":"AB266598-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
PARP1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Flow Cytometry, Immunocytochemistry, Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PARP1 also known as poly(ADP-ribose) polymerase 1 is an enzyme that plays an important role in DNA repair processes. It detects DNA single-strand breaks and uses NAD+ as a substrate to add ADP-ribose polymers to itself and other proteins. This post-translational modification signals DNA repair machinery to the site of damage. PARP1 has a molecular weight of approximately 116 kDa. It is widely expressed in the nucleus of eukaryotic cells. PARP1 is often studied by western blotting techniques to analyze its expression and activation levels.
Biological function summary

Poly(ADP-ribose) polymerase 1 functions to maintain genomic stability by acting within the base excision repair complex. This complex is important for the detection and repair of DNA damage preventing the accumulation of mutations. By acting at sites of DNA stress PARP1 facilitates the binding of DNA repair proteins stabilizing the DNA structure during the repair process. This role is significant for cells that undergo frequent DNA replication or are exposed to high levels of genotoxic stress.

Pathways

The PARP1 protein is integral to the DNA damage response and repair pathway. It interacts with other proteins such as XRCC1 to coordinate repair activities at damaged DNA sites. Another important pathway involving PARP1 is the apoptosis pathway where excessive activation of PARP1 can lead to cell death due to depletion of cellular NAD+ and ATP. This indicates its dual role in both promoting cell survival through DNA repair and contributing to cell death when damage is irreparable.

Poly(ADP-ribose) polymerase 1 is strongly linked to cancer and neurodegenerative diseases. Its activity is heightened in many cancer types where cancer cells exploit PARP1 for survival by repairing DNA damage that would otherwise be lethal. Inhibitors of PARP1 are being developed as cancer therapies to target these survival mechanisms. Moreover overactivation of PARP1 in neurodegenerative disorders like Alzheimer's disease can lead to excessive energy consumption promoting neuronal cell damage. In these contexts PARP1 connects with proteins like BRCA1 in cancer or AIF in neurodegeneration illustrating its role in disease mechanisms.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.<br>5. Once confluent passage into an appropriate flask at a density of 2x10<sup>4</sup> cells/cm<sup>2</sup>. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.</p>

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com